Erectile Dysfunction and Hypertension: Impact on Cardiovascular Risk and Treatment

Jiann, B. P. (2013). Treatment for Erectile Dysfunction in the Elderly Using Phosphodiesterase Type V Inhibitors. 台灣老年醫學暨老年學雜誌, 8(3), 147-159. https://doi.org/10.29461/TGG.201308_8(3).0001
Neves, M. F., Virdis, A., Sanjuliani, A. F., & Tibiriçá, E. V. (2013). Hypertension and Cardiometabolic Risk Factors. International Journal of Hypertension, 2013(), 373-374. https://doi.org/10.1155/2013/634798
Zhang, W., & Li, N. (2011). Prevalence, Risk Factors, and Management of Prehypertension. International Journal of Hypertension, 2011(), 570-575. https://doi.org/10.4061/2011/605359
Chen, C. F., & Lin, C. C. (2017). Vascular Access Dysfunction: An Impact on Cardiovascular Disease and Mortality?. Acta Nephrologica, 31(3), 93-94. https://doi.org/10.6221/AN.201709_31(3).0001
McFarlane, S. I., Louis, G. J., Zizi, F., Connell, A. T. W., Ogedegbe, O., Makaryus, A. N., & Maraj, I. (2011). Hypertension in the High-Cardiovascular-Risk Populations. International Journal of Hypertension, 2011(), 631-633. https://doi.org/10.4061/2011/746369